A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of a 6 mg twice a day dose
of an investigational product in subjects with diabetic neuropathy